Hypovitaminosis D is Independently Associated with Metabolic Syndrome in Obese Patients

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Barchetta, Ilaria ^a   De Bernardinis, Marzia ^a   Capoccia, Danila ^a   Baroni, Marco Giorgio ^b   Fontana, Mario ^a   Fraioli, Antonio ^a   Morini, Sergio ^c   Leonetti, Frida ^a   Cavallo, Maria Gisella ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; SEX DIFFERENCE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE; BODY MASS INDEX; CALCIFEDIOL; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PARATHYROID HORMONE; PHOSPHATES; VITAMIN D DEFICIENCY;

EID: 84881159298     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0068689     Document Type: Article

References (38)

1. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, et al. (1985) Evidence for an alteration of the vitamin D-endocrine system in obese subjects. J Clin Invest 76: 370-373.
2. Pittas AG, Lau J, Hu FB, Dawson-Hughes B, (2007) The role of vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 92: 2017-2029.
3. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ, (2008) Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 57: 2619-2625.
4. Hypponen E, Boucher BJ, Berry DJ, Power C, (2008) 25-hydroxyvitamin D, insulin-like growth factor 1 and metabolic syndrome at age 45y: a cross-sectional study in the 1958 British birth cohort. Diabetes 57: 298-305.
5. Bruyère O, Malaise O, Neuprez A, Collette J, Reginster JY, (2007) Prevalence of vitamin D inadequacy in European postmenopausal women. Curr Med Res Opin 23: 1939-1944.
6. Holick MF, (2007) Vitamin D deficiency. N Engl J Med 357(3): 266-281.
7. Pinelli NR, Jaber LA, Brown MB, Herman WH, (2010) Serum 25-hydroxy vitamin d and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care 33: 1373-1375.
8. Rosenstreich SJ, Rich C, Volwiler W, (1971) Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat. J Clin Invest Mar 50(3): 679-687.
9. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF, (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72(3): 690-693.
10. Compston JE, Vedi S, Ledger JE Webb A, Gazet JC, et al. (1981) Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 34: 2359-2363.
11. Schrager S, (2005) Dietary calcium intake and obesity. J Am Board Fam Pract 18: 205-210.
12. Barchetta I, Angelico F, Del Ben M, Baroni MG, Pozzilli P, et al. (2011) Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med 9: 85.
13. McGill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD, (2008) Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J 7: 4.
14. Muscogiuri G, Sorice GP, Prioletta A, Policola C, Della Casa S, et al. (2010) 25-Hydroxyvitamin D concentration correlates with insulin-sensitivity and BMI in obesity. Obesity (Silver Spring) 18: 1906-1910.
15. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, et al. (2004) The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89: 1196-1199.
16. Jorde R, Sneve M, Emaus N, Figenschau Y, Grimnes G, (2010) Cross- sectional and longitudinal relation between serum 25-hydroxy- vitamin D and body mass index: the Tromsø study. Eur J Nutr 49: 401-407.
17. Vilarrasa N, Vendrell J, Maravall J, Elo I, Solano E, et al. (2010) Is plasma 25(OH) D related to adipokines, inflammatory cytokines and insulin resistance in both a healthy and morbidly obese population? Endocrine 38: 235-242.
18. Yildizhan R, Kurdoglu M, Adali E, Kolusari A, Yildizhan B, et al. (2009) Serum 25-hydroxyvitamin D concentrations in obese and non-obese women with polycystic ovary syndrome. Arch Gynecol Obstet 280: 559-563.
19. Kremer R, Campbell PP, Reinhardt T, Gilsanz V, (2009) Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women. J Clin Endocrinol Metab 94: 67-73.
20. Beydoun MA, Boueiz A, Shroff MR, Beydoun HA, Wang Y, et al. (2010) Associations among 25-hydroxyvitamin D, diet quality, and metabolic disturbance differ by adiposity in adults in the United States. J Clin Endocrinol Metab 95: 3814-3827.
21. Valina-Toth AL, Lai Z, Yoo W, Abou-Samra A, Gadegbeku CA, et al. (2010) Relationship of vitamin D and parathyroid hormone with obesity and body composition in African Americans. Clin Endocrinol (Oxf) 72: 595-603.
22. Young KA, Engelman CD, Langefeld CD, Hairston KG, Haffner SM, et al. (2009) Association of plasma vitamin D levels with adiposity in Hispanic and African Americans. J Clin Endocrinol Metab 94: 3306-3313.
23. Cheng S, Massaro JM, Fox CS, Larson MG, Keyes MJ, et al. (2010) Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 59: 242-248.
24. Freedman BI, Wagenknecht LE, Hairston KG, Bowden DW, Carr JJ, et al. (2010) Vitamin D, adiposity, and calcified atherosclerotic plaque in African-Americans. J Clin Endocrinol Metab 95: 1076-1083.
25. Blum M, Dolnikowski G, Seyoum E, Harris SS, Booth SL, et al. (2008) Vitamin D(3) in fat tissue. Endocrine 33: 90-94.
26. Earthman CP, Beckman LM, Masodkar K, Sibley SD, (2012) The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications. Int J Obes (Lond). Mar 36(3): 387-96 doi:10.1038/ijo.2011.119. Epub 2011 Jun 21.
27. American Diabetes Association, (2009) Standards of medical care in diabetes-2009. Diabetes Care 32: S13-S61.
28. Holick MF, (2007) Vitamin D deficiency. N Engl J Med 357(3): 266-281.
29. DeLuca HF, (2004) Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr. 80: 1689S-1696S.
30. Jebb SA, Cole TJ, Doman D, Murgatroyd PR, Prentice AM, (2000) Evaluation of the novel Tanita body-fat analyser to measure body composition by comparison with a four-compartment model. Br J Nutr Feb 83(2): 115-122.
31. Matsuda M, DeFronzo RA, (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
32. Foss YJ, (2009) Vitamin D deficiency is the cause of common obesity. Med Hypotheses. Mar 72(3): 314-321.
33. Kull M, Kallikorm R, Lember M, (2009) Body mass index determines sunbathing habits: implications on vitamin D levels. Intern Med J 39: 256-258.
34. Florez H, Martinez R, Chacra W, Strickman-Stein N, Levis S, (2007) Outdoor exercise reduces the risk of hypovitaminosis D in the obese. J Steroid Biochem Mol Biol 103: 679-681.
35. Chacko SA, Song Y, Manson JE, Van Horn L, Eaton C, et al. (2011) Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr Jul 94(1): 209-217.
36. Deo R, Katz R, Shlipak MG, Sotoodehnia N, Psaty BM, et al. (2011) Vitamin D, parathyroid hormone, and sudden cardiac death: results from the Cardiovascular Health Study. Hypertension Dec 58(6): 1021-1028.
37. Zhao G, Ford ES, Li C, Croft JB (2011) Serum 25-hydroxyvitamin D levels and all-cause and cardiovascular disease mortality among US adults with hypertension: the NHANES linked mortality study. J Hypertens Dec 15.
38. Zhou QG, Hou FF, Guo ZJ, Liang M, Wang GB, et al. (2008) 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev 24(6): 459-64 doi:10.1002/dmrr.873.